Healthium Medtech repositions SIRONIX to target broader orthopaedic care segment

Bengaluru-based Healthium Medtech has announced the strategic rebranding of its dedicated arthroscopy business from SIRONIX Arthroscopy to ‘SIRONIX Orthopedics’, marking the next phase in its growth and expansion across the extended orthopaedic landscape.

The new identity reflects SIRONIX’s ambition to address a wider range of specialty orthopaedic care while building on its established expertise in arthroscopy and sports medicine.

Since its inception, SIRONIX has enabled surgeons with innovative arthroscopy solutions and established a strong presence in sports medicine through its surgeon partnerships and solutions. It was the first Indian company to receive EU-MDR certification for an arthroscopy portfolio, a milestone that underscores its regulatory and product development capabilities. SIRONIX also holds US FDA 510(k) clearances, alongside 80+ patents across India and the USA.

SIRONIX Orthopedics will support surgeons across the full continuum of orthopedic care, from preserving joints to restoring them, and from advanced implants to intelligent surgical technologies. The new portfolio structure will bring greater focus to its offerings while enabling SIRONIX Orthopedics to address a wider range of orthopedic needs.

Under the new identity, the portfolio will introduce four new strategic product categories:

• SIRONIX SPORTSMED – continuing its leadership on sports medicine.
• SIRONIX REGEN – focusing on solutions supporting tissue regeneration and joint preservation.
• SIRONIX RECON – addressing joint reconstruction and restoration of mobility.
• SIRONIX TECH – bringing technology-led solutions focused on surgical planning, navigation and advanced surgical capabilities.